The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
about
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara (MVA) viruses expressing African horse sickness virus VP2 antigens depends on the levels of expressed VP2 protein delivered to the host.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
The immunogenicity of recombin ...... protein delivered to the host.
@en
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara
@nl
type
label
The immunogenicity of recombin ...... protein delivered to the host.
@en
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara
@nl
prefLabel
The immunogenicity of recombin ...... protein delivered to the host.
@en
The immunogenicity of recombinant vaccines based on modified Vaccinia Ankara
@nl
P2860
P50
P1433
P1476
The immunogenicity of recombin ...... protein delivered to the host
@en
P2093
Eva Calvo-Pinilla
Peter Mertens
P2860
P304
P356
10.1016/J.ANTIVIRAL.2018.04.015
P577
2018-04-18T00:00:00Z